Mr. Karl-Ludwig Kley, the recently new CEO of Merck, stated in the Financial Times (Sept.19, 2007) that his message for staff will be "evolution not revolution". He declared his commitment to the group in its current form and the need to capitalise primarily on its existing strengths.
Nine days later, the decision to close down a preclinical oncology research laboratory in Barcelona (Spain), 34 scientists, was communicated.
What Mr.Kley said differs what Mr.Kley does.